Organon & Co.
OGNNYSEHealthcare● Active
$13.40
+$0.04(+0.26%)
Market Cap$3.5B
P/E Ratio—
52W High$13.48
52W Low$5.69
Organon & Co. (OGN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OGN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$0.71
Est. $0.83 · -14.5%
Revenue
$1.46B
Est. $1.49B · -1.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
OGN reports quarterly as a NYSE-listed Drug Manufacturers - General company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.46
Rev. $3.65B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.46
Rev. Est.$3.65B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.87 | — | — | — | $1.57B | — |
| ▼ Q2 FY2026 | Apr 30, 2026 | $0.83 | $0.71 | -14.5% | $1.46B | $1.49B | -1.9% |
| ▼ Q1 FY2026 | Feb 12, 2026 | $0.73 | $0.63 | -13.7% | $1.51B | $1.53B | -1.8% |
| ▲ Q4 FY2025 | Nov 10, 2025 | $0.93 | $1.01 | +8.6% | $1.60B | $1.52B | +5.3% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.94 | $1.00 | +6.4% | $1.59B | $1.56B | +2.1% |
| ▲ Q2 FY2025 | May 1, 2025 | $0.89 | $1.02 | +14.6% | $1.51B | $1.54B | -1.5% |
| ▼ Q1 FY2025 | Feb 13, 2025 | $0.92 | $0.90 | -2.2% | $1.59B | $1.59B | -0.0% |
| ▼ Q4 FY2024 | Oct 31, 2024 | $0.90 | $0.87 | -3.3% | $1.58B | $1.56B | +1.2% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.87
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Miss
EPS Actual
$0.71
EPS Est.
$0.83
EPS Surpr.
-14.5%
Revenue
$1.46B
Q1 FY2026
Feb 12, 2026Miss
EPS Actual
$0.63
EPS Est.
$0.73
EPS Surpr.
-13.7%
Revenue
$1.51B
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
$1.01
EPS Est.
$0.93
EPS Surpr.
+8.6%
Revenue
$1.60B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$1.00
EPS Est.
$0.94
EPS Surpr.
+6.4%
Revenue
$1.59B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$1.02
EPS Est.
$0.89
EPS Surpr.
+14.6%
Revenue
$1.51B
Q1 FY2025
Feb 13, 2025Miss
EPS Actual
$0.90
EPS Est.
$0.92
EPS Surpr.
-2.2%
Revenue
$1.59B
Q4 FY2024
Oct 31, 2024Miss
EPS Actual
$0.87
EPS Est.
$0.90
EPS Surpr.
-3.3%
Revenue
$1.58B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.78 | $0.80 | $0.81 | 2 |
| Q3 FY2027 | $0.89 | $0.91 | $0.93 | 1 |
| Q2 FY2027 | $0.91 | $0.93 | $0.95 | 1 |
| Q1 FY2027 | $0.83 | $0.84 | $0.86 | 2 |
| Q4 FY2026 | $0.76 | $0.77 | $0.79 | 2 |
| Q3 FY2026 | $0.89 | $0.92 | $0.99 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $1.5B | $1.5B | $1.6B | 1 |
| Q3 FY2027 | $1.5B | $1.6B | $1.6B | 2 |
| Q2 FY2027 | $1.5B | $1.6B | $1.6B | 2 |
| Q1 FY2027 | $1.5B | $1.5B | $1.5B | 1 |
| Q4 FY2026 | $1.5B | $1.5B | $1.6B | 2 |
| Q3 FY2026 | $1.5B | $1.6B | $1.6B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 30, 2026 | -14.5% | $13.34 | $13.25 | -0.67% |
| ▼ Q1 FY2026 | Feb 12, 2026 | -13.7% | $7.69 | $7.06 | -8.19% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +8.6% | $6.78 | $7.71 | +13.72% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +6.4% | $9.67 | $8.40 | -13.13% |
| ▲ Q2 FY2025 | May 1, 2025 | +14.6% | $12.93 | $9.45 | -26.91% |
| ▼ Q1 FY2025 | Feb 13, 2025 | -2.2% | $14.70 | $16.32 | +11.02% |
| ▼ Q4 FY2024 | Oct 31, 2024 | -3.3% | $17.93 | $18.78 | +4.74% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +5.7% | $20.19 | $18.65 | -7.63% |
Q2 FY2026-0.67%
Report Date
Apr 30, 2026
EPS Beat/Miss
-14.5%
Price Before
$13.34
Price After
$13.25
Q1 FY2026-8.19%
Report Date
Feb 12, 2026
EPS Beat/Miss
-13.7%
Price Before
$7.69
Price After
$7.06
Q4 FY2025+13.72%
Report Date
Nov 10, 2025
EPS Beat/Miss
+8.6%
Price Before
$6.78
Price After
$7.71
Q3 FY2025-13.13%
Report Date
Aug 5, 2025
EPS Beat/Miss
+6.4%
Price Before
$9.67
Price After
$8.40
Q2 FY2025-26.91%
Report Date
May 1, 2025
EPS Beat/Miss
+14.6%
Price Before
$12.93
Price After
$9.45
Q1 FY2025+11.02%
Report Date
Feb 13, 2025
EPS Beat/Miss
-2.2%
Price Before
$14.70
Price After
$16.32
Q4 FY2024+4.74%
Report Date
Oct 31, 2024
EPS Beat/Miss
-3.3%
Price Before
$17.93
Price After
$18.78
Q3 FY2024-7.63%
Report Date
Aug 6, 2024
EPS Beat/Miss
+5.7%
Price Before
$20.19
Price After
$18.65
Avg Beat Reaction-8.49%
Avg Miss Reaction+1.73%
Beat Rate4 / 8 quarters
Largest Move-26.91% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OGN ends December
Organon & Co. (OGN) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $0.71 — missing the analyst consensus of $0.83 by -14.5%. The next OGN earnings date is expected around September 1, 2026.
Each quarter, investors track OGN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OGN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OGN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OGN earnings · 5 questionsOrganon & Co.'s next earnings report is expected around September 1, 2026. OGN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OGN historically reports after market close (AMC).
OGN earnings datewhen is OGN earningsOGN next earnings datewhen does OGN report earningsOGN earnings calendar
▸ Source: FMP · Organon & Co. SEC filings · US GAAP · Organon & Co. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026